Your browser doesn't support javascript.
loading
Anosmia-A Clinical Review.
Boesveldt, Sanne; Postma, Elbrich M; Boak, Duncan; Welge-Luessen, Antje; Schöpf, Veronika; Mainland, Joel D; Martens, Jeffrey; Ngai, John; Duffy, Valerie B.
Afiliação
  • Boesveldt S; Division of Human Nutrition, Wageningen University & Research, Wageningen, The Netherlands.
  • Postma EM; Division of Human Nutrition, Wageningen University & Research, Wageningen, The Netherlands.
  • Boak D; Smell and Taste Centre, Hospital Gelderse Vallei, PO Box 9025, 6710 HN Ede, The Netherlands.
  • Welge-Luessen A; Fifth Sense, Sanderum House, 38 Oakley Road, Chino OX39 4TW, UK.
  • Schöpf V; Department of Otorhinolaryngology, University Hospital Basel, Petersgraben 4CH-4031 Basel, Switzerland.
  • Mainland JD; Institute of Psychology, University of Graz, Universitätsplatz 2, 8010 Graz, Austria.
  • Martens J; BioTechMed Graz, Mozartgasse 12/II, 8010 Graz, Austria.
  • Ngai J; Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA.
  • Duffy VB; Department of Neuroscience, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Chem Senses ; 42(7): 513-523, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28531300
Anosmia and hyposmia, the inability or decreased ability to smell, is estimated to afflict 3-20% of the population. Risk of olfactory dysfunction increases with old age and may also result from chronic sinonasal diseases, severe head trauma, and upper respiratory infections, or neurodegenerative diseases. These disorders impair the ability to sense warning odors in foods and the environment, as well as hinder the quality of life related to social interactions, eating, and feelings of well-being. This article reports and extends on a clinical update commencing at the 2016 Association for Chemoreception Sciences annual meeting. Included were reports from: a patient perspective on losing the sense of smell with information on Fifth Sense, a nonprofit advocacy organization for patients with olfactory disorders; an otolaryngologist's review of clinical evaluation, diagnosis, and management/treatment of anosmia; and researchers' review of recent advances in potential anosmia treatments from fundamental science, in animal, cellular, or genetic models. As limited evidence-based treatments exist for anosmia, dissemination of information on anosmia-related health risks is needed. This could include feasible and useful screening measures for olfactory dysfunction, appropriate clinical evaluation, and patient counseling to avoid harm as well as manage health and quality of life with anosmia.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos do Olfato Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Chem Senses Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos do Olfato Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Chem Senses Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda